← Open Payments lookup

MAEGHAN DAVIS: Open Payments

NPI 1053653824 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$322 in 14 payments from 7 companies in 2025. Trend: 2023 $558 · 2024 $354 · 2025 $322

Food & beverage: $322
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc3$70
Otsuka America Pharmaceutical, Inc.3$69
Indivior Inc.2$56
Alkermes, Inc.2$42
Teva Pharmaceuticals USA, Inc.2$37
Supernus Pharmaceuticals, Inc.1$29
Vanda Pharmaceuticals Inc.1$19

Products named: SPRAVATO, SUBLOCADE, ABILIFY ASIMTUFII, ABILIFY MAINTENA, Qelbree, ARISTADA, FANAPT, UZEDY.

Industry payments across LA — which companies pay providers there.